{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T13:38:34Z","timestamp":1793367514763,"version":"4.5.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T00:00:00Z","timestamp":1776816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T00:00:00Z","timestamp":1780617600000},"content-version":"vor","delay-in-days":44,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-026-15974-8","type":"journal-article","created":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T23:07:33Z","timestamp":1776812853000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["HPV vaccination beyond primary prevention: survey of practices and attitudes of Polish obstetrician-gynecologists"],"prefix":"10.1186","volume":"26","author":[{"given":"Dominika","family":"Trojnarska","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martyna","family":"Trzeszcz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maciej","family":"Stukan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karolina","family":"Mazurec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariola","family":"Wa\u0144tuchowicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergiusz","family":"Piasecki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karolina","family":"Grabowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maggie E.","family":"Cruickshank","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Jach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,22]]},"reference":[{"key":"15974_CR1","doi-asserted-by":"publisher","unstructured":"Nowakowski A, Jach R, Szenborn L, Bidzinski M, Jackowska T, Kotarski J et al. Recommendations of the polish society of gynaecologists and obstetricians, polish paediatric society, polish society of family medicine, polish society of vaccinology, polish society of oncological gynaecology and polish society of colposcopy and pathophysiology of the uterine cervix on prophylactic vaccinations against infections with human papillomaviruses in Poland. Ginekol Pol. 2022;VM\/OJS\/J\/90090. https:\/\/doi.org\/10.5603\/GP.a2022.0101.","DOI":"10.5603\/GP.a2022.0101"},{"key":"15974_CR2","unstructured":"Update of the PTKiPSM position statement on human papillomavirus vaccination. \u2013 2023 (Aktualizacja Stanowiska PTKiPSM dotycz\u0105cego szczepie\u0144 przeciwko wirusom brodawczaka ludzkiego\u2009\u2013\u20092023). Polish society of colposcopy and pathophysiology of the uterine cervix (Polskie Towarzystwo Kolposkopii i Patofizjologii Szyjki Macicy). Available from: https:\/\/kolposkopia.info\/rekomendajce\/aktualizacja-stanowiska-polskiego-towarzystwa-kolposkopii-i-patofizjologii-szyjki-macicy-ptkipsm-dotyczacego-szczepien-przeciwko-wirusom-brodawczaka-ludzkiego-podsumowanie-styczen-2023\/. Cited 2025 Sep 3."},{"key":"15974_CR3","unstructured":"Position statement of the board of the polish society of colposcopy and cervical pathophysiology on prophylactic HPV vaccination (Stanowisko Zarz\u0105du PTKiPSM dotycz\u0105ce szczepie\u0144 profilaktycznych przeciwko HPV). Polish society of colposcopy and cervical pathophysiology (Polskie Towarzystwo Kolposkopii i Patofizjologii Szyjki Macicy). Available from: https:\/\/kolposkopia.info\/rekomendajce\/stanowisko-zarzadu-ptkipszm-dotyczace-szczepien-profilaktycznych-przeciwko-hpv\/.\u00a0\u00a0Cited 2025 Sep 3."},{"key":"15974_CR4","unstructured":"Who is covered by the universal HPV vaccination program in 2024?. (Kogo dotyczy powszechny program szczepie\u0144 przeciw HPV w 2024 roku?). Available from: https:\/\/szczepienia.pzh.gov.pl\/faq\/kogo-dotyczy-powszechny-program-szczepien-przeciw-hpv-w-2024-roku\/. Ccited 2025 Sep 3."},{"key":"15974_CR5","unstructured":"List of prequalified vaccines | WHO -. Prequalification of medical products (IVDs, medicines, vaccines and immunization devices, vector control). Available from: https:\/\/extranet.who.int\/prequal\/vaccines\/list-prequalified-vaccines. Cited 2026 Mar 18."},{"issue":"5","key":"15974_CR6","doi-asserted-by":"publisher","first-page":"EVIDoa2100056","DOI":"10.1056\/EVIDoa2100056","volume":"1","author":"RV Barnabas","year":"2022","unstructured":"Barnabas RV, Brown ER, Onono MA, Bukusi EA, Njoroge B, Winer RL, et al. Efficacy of single-dose HPV vaccination among young African women. NEJM Evid. 2022;1(5):EVIDoa2100056. https:\/\/doi.org\/10.1056\/EVIDoa2100056. PubMed PMID: 35693874; PubMed Central PMCID: PMC9172784.","journal-title":"NEJM Evid"},{"key":"15974_CR7","doi-asserted-by":"publisher","first-page":"101361","DOI":"10.1016\/j.lana.2025.101361","volume":"55","author":"EA Burger","year":"2026","unstructured":"Burger EA, Laprise JF, Spencer JC, Sy S, Regan MC, Drolet M, et al. Single-dose HPV vaccination in the United States - a multi-modeling analysis. Lancet Reg Health Am. 2026;55:101361. https:\/\/doi.org\/10.1016\/j.lana.2025.101361. PubMed PMID: 41586382; PubMed Central PMCID: PMC12825051.","journal-title":"Lancet Reg Health Am"},{"issue":"1","key":"15974_CR8","doi-asserted-by":"publisher","first-page":"2330","DOI":"10.1186\/s12889-025-23496-4","volume":"25","author":"M Jeong","year":"2025","unstructured":"Jeong M, Jang I. Comparative effectiveness and immunogenicity of single-dose and multi-dose human papillomavirus vaccination: a systematic review. BMC Public Health. 2025;25(1):2330. https:\/\/doi.org\/10.1186\/s12889-025-23496-4. PubMed PMID: 40610947; PubMed Central PMCID: PMC12225068.","journal-title":"BMC Public Health"},{"key":"15974_CR9","unstructured":"Oncology guidelines program. cervical cancer prevention (leitlinienprogramm onkologie: Zervixkarzinom-Pr\u00e4vention). Available from: https:\/\/www.leitlinienprogramm-onkologie.de\/leitlinien\/zervixkarzinom-praevention\/. Cited 2025 Aug 27."},{"key":"15974_CR10","unstructured":"GOV.UK. HPV vaccination guidance for healthcare practitioners. Available from: https:\/\/www.gov.uk\/government\/publications\/hpv-universal-vaccination-guidance-for-health-professionals\/hpv-vaccination-guidance-for-healthcare-practitioners. Cited 2025 Aug 27."},{"key":"15974_CR11","doi-asserted-by":"publisher","first-page":"101337","DOI":"10.1016\/j.lanepe.2025.101337","volume":"55","author":"M Petr\u00e1\u0161","year":"2025","unstructured":"Petr\u00e1\u0161 M, Lomozov\u00e1 D, Dvo\u0159\u00e1k V, Dvo\u0159\u00e1k V, Malinov\u00e1 J, Trnkov\u00e1 M, et al. Early and long-term effects of prophylactic and post-excision human papillomavirus vaccination on recurrent high-grade cervical intraepithelial neoplasia relative to margin status: a retrospective cohort study in the Czech Republic. Lancet Reg Health - Europe. 2025;55:101337. https:\/\/doi.org\/10.1016\/j.lanepe.2025.101337.","journal-title":"Lancet Reg Health - Europe"},{"key":"15974_CR12","doi-asserted-by":"publisher","DOI":"10.5603\/GP.a2021.0228","author":"D Trojnarska","year":"2022","unstructured":"Trojnarska D, Baran R, Babczyk D, Jach R. A survey of knowledge, attitudes and awareness of the HPV and HPV vaccine among obstetricians and gynecologists across Poland. Ginekol Pol. 2022. https:\/\/doi.org\/10.5603\/GP.a2021.0228. VM\/OJS\/J\/86113.","journal-title":"Ginekol Pol"},{"issue":"10","key":"15974_CR13","doi-asserted-by":"publisher","first-page":"1980","DOI":"10.1111\/aogs.70027","volume":"104","author":"A Heinonen","year":"2025","unstructured":"Heinonen A, Kalliala I, Hammer A, Cruickshank M, Carcopino X, Strander B, et al. Survey of practices in the European Federation for Colposcopy: HPV vaccination after treatment for cervical precancerous lesions. Acta Obstet Gynecol Scand. 2025;104(10):1980\u20135. https:\/\/doi.org\/10.1111\/aogs.70027.","journal-title":"Acta Obstet Gynecol Scand"},{"key":"15974_CR14","doi-asserted-by":"publisher","unstructured":"Markowitz LE, Unger ER. Human Papillomavirus Vaccination. Solomon CG, editor. N Engl J Med. 2023;388(19):1790\u20138. https:\/\/doi.org\/10.1056\/NEJMcp2108502.","DOI":"10.1056\/NEJMcp2108502"},{"issue":"14","key":"15974_CR15","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1056\/NEJMoa1917338","volume":"383","author":"J Lei","year":"2020","unstructured":"Lei J, Ploner A, Elfstr\u00f6m KM, Wang J, Roth A, Fang F, et al. HPV Vaccination and the Risk of Invasive Cervical Cancer. N Engl J Med. 2020;383(14):1340\u20138. https:\/\/doi.org\/10.1056\/NEJMoa1917338.","journal-title":"N Engl J Med"},{"issue":"6","key":"15974_CR16","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1093\/jnci\/djae042","volume":"116","author":"M Arbyn","year":"2024","unstructured":"Arbyn M, Rousta P, Bruni L, Schollin Ask L, Basu P. Linkage of individual-patient data confirm protection of prophylactic human papillomavirus vaccination against invasive cervical cancer. JNCI: J Natl Cancer Inst. 2024;116(6):775\u20138. https:\/\/doi.org\/10.1093\/jnci\/djae042.","journal-title":"JNCI: J Natl Cancer Inst"},{"issue":"24","key":"15974_CR17","doi-asserted-by":"publisher","first-page":"2421","DOI":"10.1056\/NEJMoa2506765","volume":"393","author":"AR Kreimer","year":"2025","unstructured":"Kreimer AR, Porras C, Liu D, Hildesheim A, Carvajal LJ, Ocampo R, et al. Noninferiority of one HPV vaccine dose to two doses. N Engl J Med. 2025;393(24):2421\u201333. 10. 1056\/NEJMoa2506765 PubMed PMID: 41337735.","journal-title":"N Engl J Med"},{"issue":"97","key":"15974_CR18","first-page":"645","volume":"50","author":"World Health Organization","year":"2022","unstructured":"World Health Organization. Human papillomavirus vaccines: WHO position paper. Wkly Epidemiol Rec. 2022;50(97):645\u201372.","journal-title":"Wkly Epidemiol Rec"},{"issue":"12","key":"15974_CR19","doi-asserted-by":"publisher","first-page":"2075","DOI":"10.1002\/ijc.34882","volume":"154","author":"T Wen","year":"2024","unstructured":"Wen T, Xu X, Zhao X, Pan C, Feng Y, You T, et al. Efficacy and immunogenicity of AS04-HPV \u201016\/18 vaccine in females with existing cervical HR\u2010HPV infection at first vaccination: a pooled analysis of four large clinical trials worldwide. Intl J Cancer. 2024;154(12):2075\u201389. https:\/\/doi.org\/10.1002\/ijc.34882.","journal-title":"Intl J Cancer"},{"issue":"2","key":"15974_CR20","doi-asserted-by":"publisher","first-page":"100378","DOI":"10.1016\/j.ijgc.2024.100378","volume":"35","author":"J Kacperczyk-Bartnik","year":"2025","unstructured":"Kacperczyk-Bartnik J, Arbyn M, Deno\u00ebl S, Dhollander N, Razumova Z, Theofanakis C, et al. Prophylactic HPV vaccination in patients with gynaecologic cancer: practices, challenges, and recommendations reported in the ESGO-PERCH HPV survey. Int J Gynecol Cancer. 2025;35(2):100378. https:\/\/doi.org\/10.1016\/j.ijgc.2024.100378.","journal-title":"Int J Gynecol Cancer"},{"issue":"10","key":"15974_CR21","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1016\/S1473-3099(","volume":"16","author":"CM Wheeler","year":"2016","unstructured":"Wheeler CM, Skinner SR, Del Rosario-Raymundo MR, Garland SM, Chatterjee A, Lazcano-Ponce E, et al. Efficacy, safety, and immunogenicity of the human papillomavirus 16\/18 AS04-adjuvanted vaccine in women older than 25 years: 7-year follow-up of the phase 3, double-blind, randomised controlled VIVIANE study. Lancet Infect Dis. 2016;16(10):1154\u201368. https:\/\/doi.org\/10.1016\/S1473-3099(. 16)30120-7 PubMed PMID: 27373900.","journal-title":"Lancet Infect Dis"},{"issue":"42","key":"15974_CR22","doi-asserted-by":"publisher","first-page":"6194","DOI":"10.1016\/j.vaccine.2023.08.047","volume":"41","author":"M Reuschenbach","year":"2023","unstructured":"Reuschenbach M, Doorbar J, Del Pino M, Joura EA, Walker C, Drury R, et al. Prophylactic HPV vaccines in patients with HPV-associated diseases and cancer. Vaccine. 2023;41(42):6194\u2013205. https:\/\/doi.org\/10.1016\/j.vaccine.2023.08.047.","journal-title":"Vaccine"},{"issue":"mar27 3","key":"15974_CR23","doi-asserted-by":"publisher","first-page":"e1401","DOI":"10.1136\/bmj.e1401","volume":"344","author":"EA Joura","year":"2012","unstructured":"Joura EA, Garland SM, Paavonen J, Ferris DG, Perez G, Ault KA, et al. Effect of the human papillomavirus (HPV) quadrivalent vaccine in a subgroup of women with cervical and vulvar disease: retrospective pooled analysis of trial data. BMJ. 2012;344(mar27 3):e1401\u20131401. https:\/\/doi.org\/10.1136\/bmj.e1401.","journal-title":"BMJ"},{"issue":"3","key":"15974_CR24","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1016\/j.ygyno.2013.05.033","volume":"130","author":"R De Vincenzo","year":"2013","unstructured":"De Vincenzo R, Ricci C, Conte C, Scambia G. HPV vaccine cross-protection: Highlights on additional clinical benefit. Gynecol Oncol. 2013;130(3):642\u201351. https:\/\/doi.org\/10.1016\/j.ygyno.2013.05.033.","journal-title":"Gynecol Oncol"},{"issue":"12","key":"15974_CR25","doi-asserted-by":"publisher","first-page":"2812","DOI":"10.1002\/ijc.30391","volume":"139","author":"SM Garland","year":"2016","unstructured":"Garland SM, Paavonen J, Jaisamrarn U, Naud P, Salmer\u00f3n J, Chow S, et al. Prior human papillomavirus-16\/18 AS04\u2010adjuvanted vaccination prevents recurrent high grade cervical intraepithelial neoplasia after definitive surgical therapy: post\u2010hoc analysis from a randomized controlled trial. Intl J Cancer. 2016;139(12):2812\u201326. https:\/\/doi.org\/10.1002\/ijc.30391.","journal-title":"Intl J Cancer"},{"issue":"8","key":"15974_CR26","doi-asserted-by":"publisher","first-page":"1903","DOI":"10.1002\/ijc.24794","volume":"126","author":"Y Kim","year":"2010","unstructured":"Kim Y, Lee JM, Hur S, Cho C, Kim YT, Kim SC, et al. Clearance of human papillomavirus infection after successful conization in patients with cervical intraepithelial neoplasia. Intl J Cancer. 2010;126(8):1903\u20139. https:\/\/doi.org\/10.1002\/ijc.24794.","journal-title":"Intl J Cancer"},{"issue":"2","key":"15974_CR27","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1016\/j.virol.2008.10.004","volume":"384","author":"IH Frazer","year":"2009","unstructured":"Frazer IH. Interaction of human papillomaviruses with the host immune system: a well evolved relationship. Virology. 2009;384(2):410\u20134. https:\/\/doi.org\/10.1016\/j.virol.2008.10.004.","journal-title":"Virology"},{"issue":"4","key":"15974_CR28","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1080\/21645515.2017.1407896","volume":"14","author":"M Zurek Munk-Madsen","year":"2018","unstructured":"Zurek Munk-Madsen M, Toft L, Kube T, Richter R, Ostergaard L, S\u00f8gaard OS, et al. Cellular immunogenicity of human papillomavirus vaccines Cervarix and Gardasil in adults with HIV infection. Hum Vaccines Immunotherapeutics. 2018;14(4):909\u201316. https:\/\/doi.org\/10.1080\/21645515.2017.1407896.","journal-title":"Hum Vaccines Immunotherapeutics"},{"issue":"41","key":"15974_CR29","doi-asserted-by":"publisher","first-page":"6402","DOI":"10.1016\/j.vaccine.2020.07.055","volume":"38","author":"M Jentschke","year":"2020","unstructured":"Jentschke M, Kampers J, Becker J, Sibbertsen P, Hillemanns P. Prophylactic HPV vaccination after conization: a systematic review and meta-analysis. Vaccine. 2020;38(41):6402\u20139. https:\/\/doi.org\/10.1016\/j.vaccine.2020.07.055.","journal-title":"Vaccine"},{"issue":"6","key":"15974_CR30","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1136\/ijgc-2020-001197","volume":"30","author":"HC Bartels","year":"2020","unstructured":"Bartels HC, Postle J, Rogers AC, Brennan D. Prophylactic human papillomavirus vaccination to prevent recurrence of cervical intraepithelial neoplasia: a meta-analysis. Int J Gynecol Cancer. 2020;30(6):777\u201382. https:\/\/doi.org\/10.1136\/ijgc-2020-001197.","journal-title":"Int J Gynecol Cancer"},{"issue":"8","key":"15974_CR31","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1136\/sextrans-2023-055793","volume":"99","author":"M Petr\u00e1\u0161","year":"2023","unstructured":"Petr\u00e1\u0161 M, Dvo\u0159\u00e1k V, Lomozov\u00e1 D, M\u00e1\u010dal\u00edk R, Neradov\u00e1 S, Dlouh\u00fd P, et al. Timing of HPV vaccination as adjuvant treatment of CIN2\u2009+\u2009recurrence in women undergoing surgical excision: a meta-analysis and meta-regression. Sex Transm Infect. 2023;99(8):561\u201370. https:\/\/doi.org\/10.1136\/sextrans-2023-055793.","journal-title":"Sex Transm Infect"},{"issue":"2","key":"15974_CR32","doi-asserted-by":"publisher","first-page":"239","DOI":"10.3390\/vaccines10020239","volume":"10","author":"V Di Donato","year":"2022","unstructured":"Di Donato V, Caruso G, Bogani G, Cavallari EN, Palaia G, Perniola G, et al. HPV vaccination after primary treatment of HPV-related disease across different organ sites: a multidisciplinary comprehensive review and meta-analysis. Vaccines. 2022;10(2):239. https:\/\/doi.org\/10.3390\/vaccines10020239.","journal-title":"Vaccines"},{"issue":"3","key":"15974_CR33","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1002\/ijc.32752","volume":"147","author":"FL Sand","year":"2020","unstructured":"Sand FL, Kjaer SK, Frederiksen K, Dehlendorff C. Risk of cervical intraepithelial neoplasia grade 2 or worse after conization in relation to HPV vaccination status. Intl J Cancer. 2020;147(3):641\u20137. https:\/\/doi.org\/10.1002\/ijc.32752.","journal-title":"Intl J Cancer"},{"key":"15974_CR34","unstructured":"Nonavalent prophylactic HPV vaccine (GARDASIL9.) After local conservative the NOVEL trial (NOVEL). https:\/\/www.clinicaltrials.gov\/study\/NCT03979014."},{"key":"15974_CR35","unstructured":"HOPE9. Impact on disease relapse of HPV vaccination in women treated with LEEP for cervical intraepithelial neoplasia; 2018-003507\u201019 (EudraCT Number). https:\/\/www.clinicaltrials.gov\/study\/nct03848039."},{"key":"15974_CR36","doi-asserted-by":"publisher","first-page":"101585","DOI":"10.1016\/j.eclinm.2022.101585","volume":"52","author":"L Staadegaard","year":"2022","unstructured":"Staadegaard L, R\u00f6nn MM, Soni N, Bellerose ME, Bloem P, Brisson M, et al. Immunogenicity, safety, and efficacy of the HPV vaccines among people living with HIV: A systematic review and meta-analysis. eClinicalMedicine. 2022;52:101585. https:\/\/doi.org\/10.1016\/j.eclinm.2022.101585.","journal-title":"eClinicalMedicine"},{"key":"15974_CR37","unstructured":"Immunizations for preventable diseases in adults and adolescents with HIV. Adult and adolescent oIs | NIH. 2025. Available from: https:\/\/clinicalinfo.hiv.gov\/en\/guidelines\/hiv-clinical-guidelines-adult-and-adolescent-opportunistic-infections\/immunizations.\u00a0\u00a0Cited 2025 Oct 1."},{"key":"15974_CR38","unstructured":"Recommended vaccines for people. before and after a solid organ transplant | The Australian Immunisation Handbook. 2024. Available from: https:\/\/immunisationhandbook.health.gov.au\/resources\/tables\/table-recommended-vaccines-for-people-before-and-after-a-solid-organ-transplant. Cited 2025 Oct 1."},{"issue":"4","key":"15974_CR39","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1097\/CEJ.0000000000000866","volume":"33","author":"D Trojnarska","year":"2024","unstructured":"Trojnarska D, Jach R. Primary prevention of HPV-related diseases from the patients\u2019 perspective in Poland. Eur J Cancer Prev. 2024;33(4):299\u2013308. https:\/\/doi.org\/10.1097\/CEJ.0000000000000866.","journal-title":"Eur J Cancer Prev"},{"issue":"1","key":"15974_CR40","doi-asserted-by":"publisher","first-page":"2505354","DOI":"10.1080\/21645515.2025.2505354","volume":"21","author":"X Li","year":"2025","unstructured":"Li X, Zheng J, Zhang Z, Fu D, Zhao L, Li H, et al. An investigation of HPV vaccination willingness and influential factors among college students in Beijing based on the BeSD framework and evaluation of momentary intervention effect. Hum Vaccines Immunotherapeutics. 2025;21(1):2505354. https:\/\/doi.org\/10.1080\/21645515.2025.2505354.","journal-title":"Hum Vaccines Immunotherapeutics"},{"issue":"1","key":"15974_CR41","doi-asserted-by":"publisher","first-page":"30369","DOI":"10.1038\/s41598-025-16299-5","volume":"15","author":"Y Xu","year":"2025","unstructured":"Xu Y, Wang W, Cheng C, Yang L, Xing C, Yang X, et al. Factors influencing HPV vaccination willingness among male college students in Jinan according to the health belief model. Sci Rep. 2025;15(1):30369. https:\/\/doi.org\/10.1038\/s41598-025-16299-5.","journal-title":"Sci Rep"},{"issue":"1","key":"15974_CR42","doi-asserted-by":"publisher","first-page":"51","DOI":"10.4274\/tjod.galenos.2024.31369","volume":"21","author":"EG Top\u00e7u","year":"2024","unstructured":"Top\u00e7u EG, Ubom AE, Roy P, Ruiloba F. A global study on knowledge and perception of HPV and HPV vaccination among young obstetricians and gynecologists. Turk J Obstet Gynecol. 2024;21(1):51\u20136. https:\/\/doi.org\/10.4274\/tjod.galenos.2024.31369. PubMed PMID: 38440968; PubMed Central PMCID: PMC10920966.","journal-title":"Turk J Obstet Gynecol"},{"key":"15974_CR43","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.pvr.2018.03.001","volume":"5","author":"C Stanley","year":"2018","unstructured":"Stanley C, Secter M, Chauvin S, Selk A. HPV vaccination in male physicians: a survey of gynecologists and otolaryngology surgeons\u2019 attitudes towards vaccination in themselves and their patients. Papillomavirus Res. 2018;5:89\u201395. https:\/\/doi.org\/10.1016\/j.pvr.2018.03.001.","journal-title":"Papillomavirus Res"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-026-15974-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-15974-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-15974-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T00:46:28Z","timestamp":1780620388000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12885-026-15974-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,22]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["15974"],"URL":"https:\/\/doi.org\/10.1186\/s12885-026-15974-8","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,22]]},"assertion":[{"value":"31 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in accordance with the principles of the Declaration of Helsinki and received ethical approval from the Jagiellonian University Medical College Research Ethics Committee (Approval No. 118.0043.1.312.2024, dated 25.10.2024). No ethical concerns were raised regarding the conduct of the study. The authors obtained permission from the dataset owner to use the information in databases\/repositories for research purposes. Written informed consent was obtained from each participant.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"707"}}